One More Reason Halfway Socialized Healthcare is the Worst

A few years ago, a company called Genentech developed a cancer treatment it called Avastin. Avastin was a very expensive and dubiously effective cancer treatment, but it turned out to be great at treating Wet Age-Related Macular Degeneration—an eye disease that causes blindness in older patients. Another plus—an extraordinarily small dose of Avastin was sufficient to treat AMD, so using it for this purpose was very inexpensive. But then some bad PR started circulating about Avastin’s side Read more […]